Andrey Semechkin - 06 Nov 2023 Form 4 Insider Report for International Stem Cell CORP (ISCO)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Russell Kern, Attorney-in-Fact
Issuer symbol
ISCO
Transactions as of
06 Nov 2023
Net transactions value
$0
Form type
4
Filing time
08 Nov 2023, 13:18:18 UTC
Previous filing
26 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISCO Stock Option (Right to Buy) Award $0 +500,000 $0.000000 500,000 06 Nov 2023 Common Stock 500,000 $0.1200 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 3/36th of the shares underlying such options shall vest on 2/06/2024, and the remaining share in equal monthly installments over a period of 33 months.